scholarly journals Human microbiota modulation via QseC sensor kinase mediated in the Escherichia coli O104:H4 outbreak strain infection in microbiome model

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Tamara Renata Machado Ribeiro ◽  
Mateus Kawata Salgaço ◽  
Maria Angela Tallarico Adorno ◽  
Miriam Aparecida da Silva ◽  
Roxane Maria Fontes Piazza ◽  
...  
Keyword(s):  
Intestinal Microbiota ◽  
Shiga Toxin ◽  
Pathogenic Bacteria ◽  
Short Chain Fatty Acids ◽  
Sensor Kinase ◽  
Mice Model ◽  
Outbreak Strain ◽  
In Vivo Models ◽  
Histidine Sensor Kinase

Abstract Background The intestinal microbiota plays a crucial role in human health, adjusting its composition and the microbial metabolites protects the gut against invading microorganisms. Enteroaggregative E. coli (EAEC) is an important diarrheagenic pathogen, which may cause acute or persistent diarrhea (≥14 days). The outbreak strain has the potent Shiga toxin, forms a dense biofilm and communicate via QseBC two-component system regulating the expression of many important virulence factors. Results Herein, we investigated the QseC histidine sensor kinase role in the microbiota shift during O104:H4 C227–11 infection in the colonic model SHIME® (Simulator of the Human Intestinal Microbial Ecosystem) and in vivo mice model. The microbiota imbalance caused by C227–11 infection affected ỿ-Proteobacteria and Lactobacillus spp. predominance, with direct alteration in intestinal metabolites driven by microbiota change, such as Short-chain fatty acids (SCFA). However, in the absence of QseC sensor kinase, the microbiota recovery was delayed on day 3 p.i., with change in the intestinal production of SCFA, like an increase in acetate production. The higher predominance of Lactobacillus spp. in the microbiota and significant augmented qseC gene expression levels were also observed during C227–11 mice infection upon intestinal depletion. Novel insights during pathogenic bacteria infection with the intestinal microbiota were observed. The QseC kinase sensor seems to have a role in the microbiota shift during the infectious process by Shiga toxin-producing EAEC C227–11. Conclusions The QseC role in C227–11 infection helps to unravel the intestine microbiota modulation and its metabolites during SHIME® and in vivo models, besides they contribute to elucidate bacterial intestinal pathogenesis and the microbiota relationships.

scholarly journals Periplaneta americana Oligosaccharides Exert Anti-Inflammatory Activity through Immunoregulation and Modulation of Gut Microbiota in Acute Colitis Mice Model

Molecules ◽  
2021 ◽  
Vol 26 (6) ◽  
pp. 1718
Author(s):  
Kaimin Lu ◽  
Jing Zhou ◽  
Jie Deng ◽  
Yangjun Li ◽  
Chuanfang Wu ◽  
...  
Keyword(s):  
Side Effects ◽  
Pathogenic Bacteria ◽  
Periplaneta Americana ◽  
Biochemical Characterization ◽  
Antioxidant Activities ◽  
Inflammatory Activity ◽  
Mice Model ◽  
Acute Colitis ◽  
Anti Inflammatory

The incidence and prevalence of inflammatory bowel disorders (IBD) are increasing around the world due to bacterial infection, abnormal immune response, etc. The conventional medicines for IBD treatment possess serious side effects. Periplaneta americana (P. americana), a traditional Chinese medicine, has been used to treat arthritis, fever, aches, inflammation, and other diseases. This study aimed to evaluate the anti-inflammatory effects of oligosaccharides from P. Americana (OPA) and its possible mechanisms in vivo. OPA were purified and biochemical characterization was analyzed by HPGPC, HPLC, FT-IR, and GC–MS. Acute colitis mice model was established, the acute toxicity and anti-inflammatory activity were tested in vivo. The results showed OPA with molecular mass of 1.0 kDa were composed of 83% glucose, 6% galactose, 11% xylose, and the backbone was (1→4)-Glcp. OPA had potent antioxidant activities in vitro and significantly alleviated the clinical symptoms of colitis, relieved colon damage without toxic side effects in vivo. OPA exhibited anti-inflammatory activity by regulating Th1/Th2, reducing oxidative stress, preserving intestinal barrier integrity, and inhibiting TLR4/MAPK/NF-κB pathway. Moreover, OPA protected gut by increasing microbial diversity and beneficial bacteria, and reducing pathogenic bacteria in feces. OPA might be the candidate of complementary and alternative medicines of IBD with low-cost and high safety.

scholarly journals Probiotic and Functional Properties of Limosilactobacillus reuteri INIA P572

Nutrients ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1860
Author(s):  
Patricia Diez-Echave ◽  
Izaskun Martín-Cabrejas ◽  
José Garrido-Mesa ◽  
Susana Langa ◽  
Teresa Vezza ◽  
...  
Keyword(s):  
In Vitro Assays ◽  
Immunomodulatory Activity ◽  
Probiotic Properties ◽  
Protective Effects ◽  
Mice Model ◽  
In Vivo Models ◽  
Food Borne ◽  
Gastrointestinal Conditions

Limosilactobacillus reuteri INIA P572 is a strain able to produce the antimicrobial compound reuterin in dairy products, exhibiting a protective effect against some food-borne pathogens. In this study, we investigated some probiotic properties of this strain such as resistance to gastrointestinal passage or to colonic conditions, reuterin production in a colonic environment, and immunomodulatory activity, using different in vitro and in vivo models. The results showed a high resistance of this strain to gastrointestinal conditions, as well as capacity to grow and produce reuterin in a human colonic model. Although the in vitro assays using the RAW 264.7 macrophage cell line did not demonstrate direct immunomodulatory properties, the in vivo assays using a Dextran Sulphate Sodium (DSS)-induced colitic mice model showed clear immunomodulatory and protective effects of this strain.

scholarly journals The Effects of Iron and Zinc Biofortified Foods on Gut Microbiome, In Vivo (Gallus gallus): Systematic Analysis

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 1324-1324
Author(s):  
Robert Rossi ◽  
Nikita Agarwal ◽  
Jacquelyn Cheng
Keyword(s):  
Gut Microbiota ◽  
Gut Microbiome ◽  
Pathogenic Bacteria ◽  
Experimental Studies ◽  
Short Chain Fatty Acids ◽  
Gallus Gallus ◽  
Systematic Analysis ◽  
Micronutrient Status ◽  
Iron And Zinc

Abstract Objectives Systematically analyze in-vivo (Gallus gallus) experimental studies that evaluate the effects of Fe and Zn biofortified foods or their derivatives on gut microbiota modulation. Methods The review was carried out in accordance with the Preferred Reporting Items for Systematic review and Meta-Analysis (PRISMA) guidelines. Two researchers independently performed the data search at PubMed, Web of Science, Science Direct, and Scopus databases for experimental studies conducted in animal models published from January 2010 until December 2020. Five studies from the collection of 592 were selected based on the inclusion and exclusion criteria and analyzed. Results The studies indicated the dietary consumption of about 50% Fe and Zn biofortified foods provided several health benefits and improved the gut microbiome. Consumption of Fe and Zn biofortified foods was linked to increased abundance and capacity of short chain fatty acids and lactic acid producing bacteria, resulting in improved micronutrient solubility and absorption in the host. Further, a decrease in potentially pathogenic bacteria such as Streptococcus, Escherichia, and Enterobacter was linked to the consumption of Fe and Zn biofortified foods. Conclusions Dietary deficiencies of iron and zinc are common health concerns worldwide. Bacteria that colonize the gastrointestinal tract depend on micronutrients to maintain their activities, and gut microbiota compositional analysis may be an effective tool to assess host micronutrient status. This review suggests that Fe and Zn biofortified foods utilization positively restructures the gut microbiome and improves micronutrient absorption, thereby improving human health in vulnerable populations and maintaining micronutrient status in healthy populations. Further clinical and animal studies are needed to support the effects mentioned above. Funding Sources N/A.

scholarly journals Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome

2018 ◽  
Vol 28 (9) ◽  
pp. 1413-1425 ◽  
Author(s):  
Yu-Jin Jeong ◽  
Sung-Kyun Park ◽  
Sung-Jin Yoon ◽  
Young Jun Park ◽  
Moo-Seung Lee
Keyword(s):  
Hemolytic Uremic Syndrome ◽  
Shiga Toxin ◽  
In Vivo Models ◽  
Uremic Syndrome

scholarly journals Anti-Inflammatory Activities of Pentaherbs formula and Its Influence on Gut Microbiota in Allergic Asthma

Molecules ◽  
2018 ◽  
Vol 23 (11) ◽  
pp. 2776 ◽  
Author(s):  
Miranda Tsang ◽  
Sau-Wan Cheng ◽  
Jing Zhu ◽  
Karam Atli ◽  
Ben Chan ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Allergic Asthma ◽  
Herbal Medicines ◽  
Oral Intake ◽  
Allergic Diseases ◽  
Short Chain Fatty Acids ◽  
Mice Model ◽  
Anti Inflammatory

Allergic asthma is a highly prevalent airway inflammatory disease, which involves the interaction between the immune system, environmental and genetic factors. Co-relation between allergic asthma and gut microbiota upon the change of diet have been widely reported, implicating that oral intake of alternative medicines possess a potential in the management of allergic asthma. Previous clinical, in vivo, and in vitro studies have shown that the Pentaherbs formula (PHF) comprising five traditional Chinese herbal medicines Lonicerae Flos, Menthae Herba, Phellodendri Cortex, Moutan Cortex, and Atractylodis Rhizoma possesses an anti-allergic and anti-inflammatory potential through suppressing various immune effector cells. In the present study, to further investigate the anti-inflammatory activities of PHF in allergic asthma, intragastrical administration of PHF was found to reduce airway hyperresponsiveness, airway wall remodeling and goblet cells hyperplasia in an ovalbumin (OVA)-induced allergic asthma mice model. PHF also significantly suppressed pulmonary eosinophilia and asthma-related cytokines IL-4 and IL-33 in bronchoalveolar lavage (BAL) fluid. In addition, PHF modulated the splenic regulatory T cells population, up-regulated regulatory interleukin (IL)-10 in serum, altered the microbial community structure and the short chain fatty acids content in the gut of the asthmatic mice. This study sheds light on the anti-inflammatory activities of PHF on allergic asthma. It also provides novel in vivo evidence that herbal medicines can ameliorate symptoms of allergic diseases may potentially prevent the development of subsequent atopic disorder such as allergic asthma through the influence of the gut microbiota.

A comparison of Shiga-toxin negative Escherichia coli O157 aflagellate and intimin deficient mutants in porcine in vitro and in vivo models of infection

2006 ◽  
Vol 113 (1-2) ◽  
pp. 63-72 ◽  
Author(s):  
Angus Best ◽  
Roberto M. La Ragione ◽  
Derek Clifford ◽  
William A. Cooley ◽  
A. Robin Sayers ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Shiga Toxin ◽  
Escherichia Coli O157 ◽  
In Vivo Models

scholarly journals Genetic and Mechanistic Analyses of the Periplasmic Domain of the Enterohemorrhagic Escherichia coli QseC Histidine Sensor Kinase

2017 ◽  
Vol 199 (8) ◽  
Author(s):  
Christopher T. Parker ◽  
Regan Russell ◽  
Jacqueline W. Njoroge ◽  
Angel G. Jimenez ◽  
Ron Taussig ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Amino Acids ◽  
Shiga Toxin ◽  
Secretion System ◽  
Enterohemorrhagic Escherichia Coli ◽  
Signaling Cascade ◽  
Sensor Kinase ◽  
Type Three Secretion System ◽  
Histidine Sensor Kinase ◽  
Type Three Secretion

ABSTRACT The histidine sensor kinase (HK) QseC senses autoinducer 3 (AI-3) and the adrenergic hormones epinephrine and norepinephrine. Upon sensing these signals, QseC acts through three response regulators (RRs) to regulate the expression of virulence genes in enterohemorrhagic Escherichia coli (EHEC). The QseB, QseF, and KdpE RRs that are phosphorylated by QseC constitute a tripartite signaling cascade having different and overlapping targets, including flagella and motility, the type three secretion system encoded by the locus of enterocyte effacement (LEE), and Shiga toxin. We modeled the tertiary structure of QseC's periplasmic sensing domain and aligned the sequences from 12 different species to identify the most conserved amino acids. We selected eight amino acids conserved in all of these QseC homologues. The corresponding QseC site-directed mutants were expressed and still able to autophosphorylate; however, four mutants demonstrated an increased basal level of phosphorylation. These mutants have differential flagellar, motility, LEE, and Shiga toxin expression phenotypes. We selected four mutants for more in-depth analyses and found that they differed in their ability to phosphorylate QseB, KdpE, and QseF. This suggests that these mutations in the periplasmic sensing domain affected the region downstream of the QseC signaling cascade and therefore can influence which pathway QseC regulates. IMPORTANCE In the foodborne pathogen EHEC, QseC senses AI-3, epinephrine, and norepinephrine, increases its autophosphorylation, and then transfers its phosphate to three RRs: QseB, QseF, and KdpE. QseB controls expression of flagella and motility, KdpE controls expression of the LEE region, and QseF controls the expression of Shiga toxin. This tripartite signaling pathway must be tightly controlled, given that flagella and the type three secretion system (T3SS) are energetically expensive appendages and Shiga toxin expression leads to bacterial cell lysis. Our data suggest that mutations in the periplasmic sensing loop of QseC differentially affect the expression of the three arms of this signaling cascade. This suggests that these point mutations may change QseC's phosphotransfer preferences for its RRs.

scholarly journals Insights into the Role of the Microbiota and of Short-Chain Fatty Acids in Rubinstein–Taybi Syndrome

2021 ◽  
Vol 22 (7) ◽  
pp. 3621
Author(s):  
Elisabetta Di Fede ◽  
Emerenziana Ottaviano ◽  
Paolo Grazioli ◽  
Camilla Ceccarani ◽  
Antonio Galeone ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Neurodevelopmental Disorder ◽  
Short Chain Fatty Acids ◽  
Therapeutic Interventions ◽  
Short Chain ◽  
Patient Specific ◽  
Microbiota Composition ◽  
In Vivo Models

The short-chain fatty acid butyrate, produced by the gut microbiota, acts as a potent histone deacetylase (HDAC) inhibitor. We assessed possible ameliorative effects of butyrate, relative to other HDAC inhibitors, in in vitro and in vivo models of Rubinstein–Taybi syndrome (RSTS), a severe neurodevelopmental disorder caused by variants in the genes encoding the histone acetyltransferases CBP and p300. In RSTS cell lines, butyrate led to the patient-specific rescue of acetylation defects at subtoxic concentrations. Remarkably, we observed that the commensal gut microbiota composition in a cohort of RSTS patients is significantly depleted in butyrate-producing bacteria compared to healthy siblings. We demonstrate that the effects of butyrate and the differences in microbiota composition are conserved in a Drosophila melanogaster mutant for CBP, enabling future dissection of the gut–host interactions in an in vivo RSTS model. This study sheds light on microbiota composition in a chromatinopathy, paving the way for novel therapeutic interventions.

Sign in / Sign up

Export Citation Format

Share Document